297 related articles for article (PubMed ID: 12133075)
1. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix.
Govindaraj A; Selvam R
BJU Int; 2002 Aug; 90(3):336-44. PubMed ID: 12133075
[TBL] [Abstract][Full Text] [Related]
2. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
Srinivasan S; Kalaiselvi P; Varalakshmi P
Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
[TBL] [Abstract][Full Text] [Related]
3. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization.
Kalaiselvi P; Udayapriya KL; Selvam R
BJU Int; 1999 Jun; 83(9):919-23. PubMed ID: 10368229
[TBL] [Abstract][Full Text] [Related]
4. Effect of biomolecules from human renal matrix of calcium oxalate monohydrate (CaOx) stones on in vitro calcium phosphate crystallization.
Pathak P; Singh SK; Tandon C
Int Braz J Urol; 2010; 36(5):621-8. PubMed ID: 21044380
[TBL] [Abstract][Full Text] [Related]
5. Increased calcium oxalate crystal nucleation and aggregation by peroxidized protein of human kidney stone matrix and renal cells.
Govindaraj A; Selvam R
Urol Res; 2001 Jun; 29(3):194-8. PubMed ID: 11482446
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometric identification of human phosphate cytidylyltransferase 1 as a novel calcium oxalate crystal growth inhibitor purified from human renal stone matrix.
Priyadarshini ; Singh SK; Tandon C
Clin Chim Acta; 2009 Oct; 408(1-2):34-8. PubMed ID: 19595683
[TBL] [Abstract][Full Text] [Related]
7. Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.
Chutipongtanate S; Nakagawa Y; Sritippayawan S; Pittayamateekul J; Parichatikanond P; Westley BR; May FE; Malasit P; Thongboonkerd V
J Clin Invest; 2005 Dec; 115(12):3613-22. PubMed ID: 16308573
[TBL] [Abstract][Full Text] [Related]
8. Effect of experimental hyperoxaluria on renal calcium oxalate monohydrate binding proteins in the rat.
Kalaiselvi P; Selvam R
BJU Int; 2001 Jan; 87(1):110-6. PubMed ID: 11122003
[TBL] [Abstract][Full Text] [Related]
9. Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis.
Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
PLoS One; 2013; 8(7):e69916. PubMed ID: 23894559
[TBL] [Abstract][Full Text] [Related]
10. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.
Mushtaq S; Siddiqui AA; Naqvi ZA; Rattani A; Talati J; Palmberg C; Shafqat J
Clin Chim Acta; 2007 Sep; 384(1-2):41-7. PubMed ID: 17610860
[TBL] [Abstract][Full Text] [Related]
11. Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former.
Hess B; Jordi S; Zipperle L; Ettinger E; Giovanoli R
Nephrol Dial Transplant; 2000 Mar; 15(3):366-74. PubMed ID: 10692522
[TBL] [Abstract][Full Text] [Related]
12. Studies on calcium oxalate binding proteins: effect of lipid peroxidation.
Selvam R; Kalaiselvi P
Nephron; 2001 Jun; 88(2):163-7. PubMed ID: 11399920
[TBL] [Abstract][Full Text] [Related]
13. 2D map of proteins from human renal stone matrix and evaluation of their effect on oxalate induced renal tubular epithelial cell injury.
Aggarwal KP; Tandon S; Singh SK; Tandon C
Int Braz J Urol; 2013; 39(1):128-36. PubMed ID: 23489505
[TBL] [Abstract][Full Text] [Related]
14. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
Robertson WG
Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
[TBL] [Abstract][Full Text] [Related]
15. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
Atmani F; Khan SR
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
[TBL] [Abstract][Full Text] [Related]
16. Alpha-1-microglobulin: inhibitory effect on calcium oxalate crystallization in vitro and decreased urinary concentration in calcium oxalate stone formers.
Tardivel S; Médétognon J; Randoux C; Kébédé M; Drüeke T; Daudon M; Hennequin C; Lacour B
Urol Res; 1999 Aug; 27(4):243-9. PubMed ID: 10460893
[TBL] [Abstract][Full Text] [Related]
17. Quantification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in vitro in the urine of healthy controls and stone-forming patients.
Atmani F; Khan SR
Urol Int; 2002; 68(1):54-9. PubMed ID: 11803269
[TBL] [Abstract][Full Text] [Related]
18. Role of biomolecules from human renal stone matrix on COM crystal growth.
Aggarwal S; Tandon CD; Forouzandeh M; Singla SK; Kiran R; Jethi RK
Mol Cell Biochem; 2000 Jul; 210(1-2):109-19. PubMed ID: 10976764
[TBL] [Abstract][Full Text] [Related]
19. Discovering inhibitor molecules for pathological crystallization of CaOx kidney stones from natural extracts of medical herbs.
Li S; Macaringue EGJ; Zhou D; Shi P; Tang W; Gong J
J Ethnopharmacol; 2022 Feb; 284():114733. PubMed ID: 34644589
[TBL] [Abstract][Full Text] [Related]
20. A novel basic protein from human kidney which inhibits calcium oxalate crystal growth.
Selvam R; Kalaiselvi P
BJU Int; 2000 Jul; 86(1):7-13. PubMed ID: 10886075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
